MICROGLIA-TARGETED MRI/PET TRACEABLE NANOVECTORS: THERANOSTIC PLATFORM FOR TRACKING AND SHAPING MICROGLIA REACTIVITY TO IMPROVE ALS THERAPY
$744,068FY2017Department of the ArmyDOD
Dana-Farber Cancer Institute, Inc.
Investigators
View source on USAspending →MICROGLIA-TARGETED MRI/PET TRACEABLE NANOVECTORS: THERANOSTIC PLATFORM FOR TRACKING AND SHAPING MICROGLIA REACTIVITY TO IMPROVE ALS THERAPY · GrantIndex